Complement Activation Is Associated With Disease Severity in Multiple Sclerosis-Reference-Cited by-同舟云学术

Complement Activation Is Associated With Disease Severity in Multiple Sclerosis

Published:2024-03 Issue:2 Volume:11 Page:
ISSN:2332-7812
Container-title:Neurology Neuroimmunology & Neuroinflammation
language:en
Short-container-title:Neurol Neuroimmunol Neuroinflamm

Author:

Oechtering Johanna¹^ORCID,Stein Kerstin¹,Schaedelin Sabine A.¹^ORCID,Maceski Aleksandra M.¹,Orleth Annette¹,Meier Stephanie¹,Willemse Eline¹,Qureshi Ferhan¹,Heijnen Ingmar¹,Regeniter Axel¹,Derfuss Tobias¹^ORCID,Benkert Pascal¹^ORCID,D'Souza Marcus¹^ORCID,Limberg Marguerite¹,Fischer-Barnicol Bettina¹^ORCID,Achtnichts Lutz¹^ORCID,Mueller Stefanie¹^ORCID,Salmen Anke¹^ORCID,Lalive Patrice H.¹^ORCID,Bridel Claire¹^ORCID,Pot Caroline¹^ORCID,Du Pasquier Renaud A.¹^ORCID,Gobbi Claudio¹^ORCID,Wiendl Heinz¹^ORCID,Granziera Cristina¹^ORCID,Kappos Ludwig¹^ORCID,Trendelenburg Marten¹,Leppert David¹^ORCID,Lunemann Jan D.¹^ORCID,Kuhle Jens¹^ORCID,

Affiliation:

1. From the Department of Neurology (J.O., A.M.M., A.O., S. Meier, E.W., T.D., M.D.S., M.L., B.F.-B., C. Granziera, L.K., D.L., J.K.); Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB) (J.O., S.A.S., A.M.M., A.O., S. Meier, E.W., T.D., P.B., M.D.S., M.L., B.F.-B., C. Granziera, L.K., D.L., J.K.), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Switzerland; Department of Neurology with Institute of...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/NXI.0000000000200212

Reference45 articles.

1. The immunology of multiple sclerosis

2. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

3. Homogeneity of active demyelinating lesions in established multiple sclerosis

4. Complement activation in multiple sclerosis plaques: an immunohistochemical analysis

5. Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the complement C1q levels in serum and cerebrospinal fluid in multiple sclerosis patients: Could it serve as a valuable marker in clinical practice?;Journal of Neuroimmunology;2024-09

2. The complement system in neurodegenerative and inflammatory diseases of the central nervous system;Frontiers in Neurology;2024-07-03

3. Neurodegeneration and demyelination in multiple sclerosis;Neuron;2024-06

4. Complement Activation Is Associated With Disease Severity in Multiple Sclerosis;Neurology Neuroimmunology & Neuroinflammation;2024-05